JP2012532859A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532859A5
JP2012532859A5 JP2012519080A JP2012519080A JP2012532859A5 JP 2012532859 A5 JP2012532859 A5 JP 2012532859A5 JP 2012519080 A JP2012519080 A JP 2012519080A JP 2012519080 A JP2012519080 A JP 2012519080A JP 2012532859 A5 JP2012532859 A5 JP 2012532859A5
Authority
JP
Japan
Prior art keywords
cells
fibroblasts
regulatory
stem cells
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012519080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532859A (ja
JP5892931B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/001968 external-priority patent/WO2011004264A1/en
Publication of JP2012532859A publication Critical patent/JP2012532859A/ja
Publication of JP2012532859A5 publication Critical patent/JP2012532859A5/ja
Application granted granted Critical
Publication of JP5892931B2 publication Critical patent/JP5892931B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012519080A 2009-07-09 2010-07-09 細胞治療において使用するための方法および組成物 Active JP5892931B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22427509P 2009-07-09 2009-07-09
US61/224,275 2009-07-09
PCT/IB2010/001968 WO2011004264A1 (en) 2009-07-09 2010-07-09 Methods and compositions for use in cellular therapies

Publications (3)

Publication Number Publication Date
JP2012532859A JP2012532859A (ja) 2012-12-20
JP2012532859A5 true JP2012532859A5 (enExample) 2013-08-15
JP5892931B2 JP5892931B2 (ja) 2016-03-23

Family

ID=42782196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519080A Active JP5892931B2 (ja) 2009-07-09 2010-07-09 細胞治療において使用するための方法および組成物

Country Status (19)

Country Link
US (1) US8679834B2 (enExample)
EP (2) EP3150703A1 (enExample)
JP (1) JP5892931B2 (enExample)
KR (1) KR101788885B1 (enExample)
CN (2) CN107007626A (enExample)
AU (1) AU2010269962B2 (enExample)
BR (1) BR112012000534A2 (enExample)
CA (1) CA2767300C (enExample)
DK (1) DK2451943T3 (enExample)
ES (1) ES2479542T3 (enExample)
HU (1) HUE031921T2 (enExample)
IL (1) IL217377A (enExample)
MX (1) MX359639B (enExample)
NZ (1) NZ597975A (enExample)
PL (1) PL2451943T3 (enExample)
PT (1) PT2451943T (enExample)
RU (1) RU2610427C2 (enExample)
SG (2) SG10201403758SA (enExample)
WO (1) WO2011004264A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
SG10202001007TA (en) 2005-09-23 2020-03-30 Tigenix Sau Cell populations having immunoregulatory activity, method for isolation and uses
WO2011006029A1 (en) 2009-07-10 2011-01-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Artificial cell constructs for inducing immunological tolerance
US11090363B2 (en) 2009-07-10 2021-08-17 University of Pittsburgh—of the Commonwealth System of Higher Education Vasoactive intestinal peptide release from microparticles
JP6018081B2 (ja) * 2011-01-12 2016-11-02 ティジェニクス エス.エー.ユー. 自己免疫および炎症性疾患におけるリンパ系内投与用の脂肪由来間葉系幹細胞
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
PL2785359T3 (pl) 2011-11-30 2018-12-31 Astellas Institute For Regenerative Medicine Mezenchymalne komórki zrębowe i związane z nimi zastosowania
EP2833896A2 (en) * 2012-03-30 2015-02-11 University Of Southern California Compositions and treatment methods for mesenchymal stem cell-induced immunoregulation
CN104471059B (zh) 2012-07-12 2018-04-17 珠海横琴爱姆斯坦生物科技有限公司 人胚胎干细胞衍生的间充质样干细胞、方法及其应用
WO2016098061A1 (en) 2014-12-18 2016-06-23 Pluristem Ltd. Methods and compositions for treating and preventing muscle wasting disorders
WO2016107563A1 (zh) * 2014-12-29 2016-07-07 西比曼生物科技(上海)有限公司 一种用于治疗上呼吸道疾病的脂肪间充质祖细胞复合物
CN107864627A (zh) 2015-03-23 2018-03-30 普拉里斯坦有限公司 包含粘附基质细胞的方法和组合物
CA3012741A1 (en) 2016-02-18 2017-08-24 Pluristem Ltd. Methods and compositions for treating cancer and neoplasms
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
EP3478300B1 (en) 2016-06-30 2022-08-24 Stem Cell Medicine Ltd. Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
EP3624815A4 (en) 2017-05-15 2021-01-20 Stem Cell Medicine Ltd. TREATMENT OF MULTIPLE SCLEROSIS WITH LONG-ACTING GLATIRAMER AND ADAPTIVE STEM CELLS
IL269893B2 (en) 2017-05-15 2023-10-01 Stem Cell Medicine Ltd Treatment of multiple sclerosis with adipose-derived stem cells
CN107281469A (zh) * 2017-07-17 2017-10-24 广东颜值科技有限公司 一种细胞组合物及其制备方法和应用
CN107349419A (zh) * 2017-07-17 2017-11-17 广东颜值科技有限公司 一种细胞组合物及其制备方法和应用
CN112912087A (zh) * 2018-09-14 2021-06-04 卢卡科学株式会社 线粒体向淋巴器官中的移植以及用于该移植的组合物
WO2020191036A1 (en) * 2019-03-19 2020-09-24 Fibrogenesis Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof
WO2020243504A1 (en) * 2019-05-31 2020-12-03 Figene, Llc Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis
WO2021207192A1 (en) * 2020-04-08 2021-10-14 Figene, Llc Methods and compositions for allergy and asthma treatment using fibroblasts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040115216A1 (en) * 2002-07-12 2004-06-17 The Johns Hopkins University Reagents and methods for engaging unique clonotypic lymphocyte receptors
CN102600461B (zh) * 2002-12-06 2017-07-14 西北生物治疗药物公司 给予体外部分成熟的树突细胞治疗肿瘤
SG10202001007TA (en) 2005-09-23 2020-03-30 Tigenix Sau Cell populations having immunoregulatory activity, method for isolation and uses
US8241621B2 (en) * 2006-12-18 2012-08-14 Medistem Laboratories Stem cell mediated treg activation/expansion for therapeutic immune modulation
EP2578677A1 (en) * 2007-08-09 2013-04-10 Genzyme Corporation Method of treating autoimmune disease with mesenchymal stem cells
EP2191835A4 (en) * 2007-09-07 2011-12-14 Japan Chem Res THERAPEUTIC AND PROPHYLACTIC AGENTS FOR ARTHRITIS
WO2009134429A2 (en) * 2008-05-02 2009-11-05 Massachusetts Institute Of Technology Methods and compositions for modulating immunological tolerance
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells

Similar Documents

Publication Publication Date Title
RU2012104529A (ru) Способы и композиции для применения в клеточной терапии
ES2479544T1 (es) Células madre mesenquimales derivadas de tejido adiposo para administración intralinfática en enfermedades autoimmunes e inflamatorias
JP2014502628A5 (enExample)
ME02662B (me) Niskofrekventna terapija glatiramer acetatom
EP3190186A3 (en) Expression of mirnas in placental tissue
SG10201903512SA (en) Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases
MX2010003019A (es) Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
SI2625199T1 (en) Procedures for treating psoriasis using IL-17 antagonists
Wen et al. Roles of mesenchymal stem cells and exosomes in interstitial cystitis/bladder pain syndrome
HK1202776A1 (en) Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy
RU2014122858A (ru) Лечение когнитивных расстройств (r)-7-хлор-n-(хинуклидин-3-ил)бензо[в]тиофен-2-карбосамидом и его фармацевтически приемлемыми солями
RU2016137289A (ru) Схема применения соединения fgf-18
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
RU2012136724A (ru) Лечение или профилактика инфекции
MX2010006724A (es) Regimenes terapeuticos para el tratamiento de desordenes inmunoinflamatorios.
FI3359572T3 (fi) Menetelmä multippeliskleroosin hoitamiseksi
Ha et al. The efficacy and safety of a human perirenal adipose tissue-derived stromal vascular fraction in an interstitial cystitis rat model
WO2019241742A8 (en) Combination of ezh2 inhibitor and checkpoint therapy for the treatment of cancer
EP4241788A3 (en) Methods of treating basal cell carcinoma and glioblastoma
CN102755541B (zh) 一种筋脉失养型肩周炎用膏药
Yuce The effects of mesenchymal stem cells on asthma
Verkhnev et al. Experience in the treatment of opium withdrawal syndrome with naloxone under general anesthesia
RU2007129578A (ru) Способ комплексного лечения остроконечных кондилом урогенитального тракта
袁媛 A preliminary study of different methods of anesthesia for painless bronchoscopy
RU2012104666A (ru) Применение комбинации терифлюномида и интерферона бета для лечения рассеяного склероза